Skip to main content

Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk

Abstract

Background

Cancer is a shared family experience that might provide an opportunity for lifestyle change among at-risk family members. The purpose of this study was to assess receptivity and preferences for cancer risk reduction programs among at-risk family members with two or more relatives affected with pancreas cancer.

Methods

We surveyed 401 at-risk family members in an existing pancreatic cancer family registry. Participants completed a mailed survey which examined demographic, medical, and psychosocial correlates of willingness to participate in lifestyle cancer risk reduction programs. Multivariable generalized estimating equation approaches were used to model preferences.

Results

Overall, 85% (n = 342) of at-risk family members were receptive to lifestyle cancer risk reduction programs. Participant preferred programs focused on nutrition (36%, n = 116) and weight management (33%, n = 108), with Web/Internet (46%, n = 157) being the most preferred delivery channel. Most respondents preferred to participate in programs with their family or friends (74%, n = 182), rather than alone (25%, n = 85). In multivariable analysis, younger age (p = 0.008) and higher perceived likelihood of developing cancer (p = 0.03) were associated with willingness to participate in lifestyle programs.

Conclusions

Family members of those with pancreatic cancer are receptive to cancer risk reduction programs focusing on nutrition and weight management delivered via the internet. Further research is indicated to determine how to best incorporate a family-based approach when designing lifestyle intervention programs.

Peer Review reports

Introduction

Cancer is a shared family experience and awareness of an increased cancer risk due to family history may provide an opportunity for cancer risk reduction behaviors among at-risk but unaffected family members. With this in mind, it may be logical to approach behavior change efforts at the familial level. This situation is especially salient in the case of pancreatic cancer (PC), given its poor prognosis, limited means of treatment and diagnosis, and lack of firm information about PC prevention [14].

Pancreatic cancer is the second most common form of digestive tract cancer and the fourth leading cause of cancer death [2, 5], with an estimated 6% of patients surviving 5 years post diagnosis. Low survival rates are due to the fact that in early stages PC is largely asymptomatic, and early detection is limited [2]. The only surveillance techniques currently used to facilitate diagnosis of PC are computed tomography, magnetic resonance imaging, and endoscopic ultrasound, all of which cannot feasibly be applied to widespread use, and are not proven to reduce PC morbidity and mortality [6]. As a result, PC is one of the few cancers with little improvement in survival rates over the past 40 years.

Lifestyle risk factors, including tobacco use, physical inactivity, diet high in red meat and fat, and higher body mass index (BMI) are related to the development of PC [2, 5, 710]. Moreover, having at least one first degree relative with PC significantly increases risk as much as 2 to 5 times that of someone with no family history, and the risk is even higher for those with more than one affected relative [2, 5, 11, 12].

A cancer diagnosis has been found to be a teachable moment for health behavior change (e.g., smoking cessation) among those diagnosed [1315]. However, the timing of receptivity to behavior change in relation to the patient’s cancer diagnosis is not well understood for family members. It is possible that family members may want to make lifestyle changes after some time has passed post-diagnosis, given intense emotional reactions, fatigue related to caregiving, or concern about their own cancer risk.

While a significant amount of research has explored how caregiving duties, coping, and psychosocial distress [16] can have an impact on families, there is a paucity of research exploring how the cancer experience might influence cancer-prevention behavior change among family members. Moreover, few studies have developed and/or explored the use of family-based interventions for those diagnosed with cancer and their family members, and none currently explored this issue with respect to PC. A recent study found that 54% of cancer patients were interested in helping a friend or family member stop smoking in an effort to decrease their relative’s cancer risk [17]. Kristeller and colleagues (1996) [11] found that family members were receptive to discussing cancer and possible interventions, but that spontaneous behavior change was low among family members. Thus, it is unclear if family members initiate and make actual changes in their behavior to reduce cancer risk, even if they are receptive and willing to make changes.

Several questions remain with respect to preferences among family members for types of interventions (exercise, weight management), program format (family versus individual), and/or delivery channels (web-based versus face-to-face). Also, investigations into aspects of the family cancer experience (e.g., timing of diagnosis to program recruitment) are needed.

To address these gaps, our overall study objectives were two-fold: 1) assess receptivity and preferences for participating in cancer risk reduction programs among PC family members and 2) to identify demographic, medical, psychosocial, and behavioral characteristics associated with willingness to participate in a risk reduction intervention. These data were collected as the first step toward developing lifestyle interventions that incorporate the family cancer experience.

Methods

The study was approved by the Mayo Clinic Institutional Review Board.

Participants and procedures

Participants included at-risk unaffected family members of patients (probands) who were diagnosed and/or treated for PC at Mayo Clinic [18]. The probands were recruited into a PC patient research registry established in 2001, and had provided detailed risk factor, clinical, and family history information. Currently, the PC family registry consists of 1570 consented and living adult relatives in 264 families (212 spouses and 1358 blood relatives). Eligibility for at-risk unaffected family members included a positive family history (two or more relatives affected with PC), age 18 or older, and ability to provide written informed consent.

In March 2009, 461 subjects in the PC family registry were mailed a packet that included: 1) a cover letter explaining the purpose of the research; 2) a consent form; 3) a survey (described below) with a postage-paid, pre-addressed return envelope. A second packet was mailed to those who did not respond within approximately 6 weeks of the first mailing. No remuneration was offered for participation. Data were available for 401 (87%) participants who are the focus of this report.

Measures

Demographic and medical data were furnished by the family registry database and abstracted from medical records, including age, gender, race, marital status, education level, body mass index, smoking status, number of first degree relatives with PC, and time since PC diagnosis of the affected family member(s).

The survey was developed to address the content areas described below and then pilot-tested on 22 adults with cancer family history of PC and then revised accordingly. Psychosocial characteristics measured were perceived and comparative cancer risk (for PC and cancer generally) [4] degree of cancer worry/concern (for PC and cancer generally) [4]; degree of emotional closeness to affected family member(s) [19]; and self-efficacy for behavioral change in general [20] as well as for nutrition [21] and exercise [22].

Health behaviors assessed from the survey were physical activity (PA); Godin Leisure Time Exercise Questionnaire (GLTEQ) [23], dietary behavior over the past month [21], alcohol consumption over the past year, and smoking status obtained from the medical records.

Receptivity to participate in a cancer risk reduction lifestyle program was measured by the question, “How willing would you be to take part in a lifestyle program (i.e., exercise, nutrition, smoking cessation) to help reduce your risk of getting cancer if we were to create one?” Response categories included, “Not at all”, “Somewhat”, and “Definitely”. Those responding “Somewhat” or “Definitely” were asked five additional questions to assess program preferences. The first question was “Would you want a program that was just for you or one that includes you and your family or others?” Categories of response were “Just me”, “Me and my family”, and “Me and others (i.e., people outside family like friends or coworkers)”. The second question was “What type of lifestyle program(s) would be of interest?” with instructions to “Mark ALL that apply”. Choices included: Exercise, Weight management, Nutrition, Tobacco cessation (to quit smoking), Stress reduction, and Other (specify). The third question asked subjects to select their top choice from the types of lifestyle program(s) listed above. The fourth question was “How likely would you be to take part if the program was delivered by phone, by mail, in person, by internet?” Categories of response were on a 3-point Likert scale ranging from “Very likely” to “Not at all likely”. The fifth question invited participants to select their top choice out of the four ways to deliver the program.

Statistical analysis

Predictors of receptivity to participate (“Definitely” or “Somewhat” willing versus “Not” willing) in a health promoting lifestyle program among family members was assessed with generalized estimating equations to account for multiple family members who might participate from a given kindred. Both univariable and multivariable models were fit. Variables that were significant in univariable analyses were included in the multivariable model. In all cases, p-values <0.05 were considered statistically significant. Descriptive data are presented as frequencies (n), percentages, means, and standard deviations (SD).

Results

Respondent characteristics

Table 1 displays the characteristics of the 401 respondents. The respondents were middle aged (mean 58.5 years, range 23–96; SD = 13.4), Caucasian (98.5), mostly female (63%), highly educated (82% with more than 12 years of education), and 78% (n = 240) reported being married or having a life partner. The mean BMI of respondents was 27.9 kg/m2 (range 17.4-57.5; SD = 5.3) with 69% meeting criteria for being overweight or obese (BMI above 25). About half (51%) of the respondents reported engaging in moderate to strenuous physical activity (Godin score > 24), and most reported being in good to excellent health (88%). Respondents endorsed eating moderately healthy diets. Approximately half (48%) of indicated consuming alcohol weekly and 11% were current smokers. All respondents had one or more family members affected by PC. The time since diagnosis of the most recently affected family member was 7.2 years (range: 0–33 years; SD = 7.5).

Table 1 Pancreatic cancer family member respondent characteristics (N = 401)

Receptivity to participate in a lifestyle intervention and program preferences

Table 2 shows self-reported willingness of respondents to participate in cancer risk reduction lifestyle interventions. The majority of respondents (85.3%, n = 342) were “Somewhat” or “Definitely” willing to participate in a lifestyle cancer-reduction program. Among those receptive to the programs, about half (54%) preferred to engage in a program with other family members. The most preferred programs included nutritional information (36%) and weight management (34%), with the Web/Internet being the preferred delivery channel (46%).

Table 2 Cancer risk-reduction program receptivity among pancreatic cancer family members (N = 401)

Correlates of receptivity to participate in a lifestyle intervention

Family members who reported receptivity to lifestyle interventions (relative to those who were not receptive) were generally younger (p < 0.001), female (p = 0.01), and more educated (p = 0.012) (Table 3). Those willing to participate in risk reduction interventions were higher in subjective general self efficacy (p = 0.03), nutritional self efficacy (p = 0.02), and in exercise self efficacy (p =0.01) compared to those who were not willing. In addition, those willing to participate perceived themselves as having a greater risk of developing PC themselves (p = 0.0007), and perceived greater risk of developing other forms of cancer (p = 0.0009). Similarly, this group reported higher levels of concern about getting PC (p < 0.0001) and higher levels of concern about cancer in general (p = 0.001).

Table 3 Comparison of demographic, psychosocial and health behavior characteristics by pancreatic cancer family members receptiveness to participate in lifestyle interventions (N = 401)

The following variables were included in the multivariable model of receptivity versus not: age, gender, education, likelihood of developing cancer, concern about getting cancer, and general self-efficacy. In this model, only younger age (p = 0.008) was associated with receptivity to participate in cancer-risk reduction programs. Trend-level associations with receptivity to participate in a cancer-risk reduction program, included higher likelihood of developing cancer (p = 0.058), higher concern of developing cancer (p = 0.060).

Discussion

This study assessed the receptivity and preferences of at-risk family members from a PC family registry to participate in cancer risk reduction programs. Concurrently, we also assessed health behaviors of the participants as well as potential psychosocial correlates of such receptivity. We found that 85% of participants were at least “somewhat” receptive to lifestyle programs, with 34% preferring a program focusing on weight management and 37% preferring a program focusing on nutrition. These areas are related and have been shown in the literature to be effective in reducing cancer risk [7].

Notably, a majority (74%) reported a stronger preference for participating in risk reduction programs with their family members and friends. This novel finding suggests a new avenue for intervention development that incorporates natural sources of support [24]. A benefit of a natural source of support is that it can have a positive effect on one’s self-esteem which in turn can increase motivation and retention to changes in behavior. Additionally, a social network can provide coping resources such as emotional, informational, and instrumental support. At-risk family members and cancer survivors should be studied as an integrated family unit to better understand and conceptualize a family or group-based program. Future studies could use a multi-dimensional assessment tool (e.g., Cancer Risk Belief Scale [25]) to explore individuals’ ideas about the role of family in cancer risk or employ qualitative methods to achieve a more in-depth understanding.

Among respondents who were receptive to participating in risk reduction lifestyle programs, 71% meet the criteria of being overweight or obese, and 69% self-reported lower levels of physical activity, suggesting unhealthy lifestyles in this group. However, these respondents self-reported higher levels in general, nutritional, and exercise self-efficacy, reflecting that this group may be more confident in their ability to start making behavioral changes (e.g. initiate weight loss programs and nutritional information sessions). Thus, there may be tension between intentions to change versus making an actual change in lifestyle behavior, which may explain why approximately half (n = 167) of these respondents reported being “somewhat” rather than “definitely” receptive. Therefore, it is important for lifestyle programs to address barriers such as lack of motivation and retention in intervention efforts.

Our findings suggest that concern about developing cancer appears to be the largest motivating factor for willingness to participate in cancer risk reduction programs in the family members. This willingness may be due to the lethality of this cancer and the poor prognosis of those diagnosed with PC. Similarly, it can be posited that there may be more grief or impending loss concerns among the family members which may minimize their receptivity to participate in risk reduction programs. Thus, further exploration is needed to determine how to approach grief and loss concerns in future program development and recruitment efforts.

With respect to program delivery channels, family members preferred Web/Internet over other options. This preference could be due to the fact that family members in the study were geographically dispersed; and that participants’ average age was less than 50 which might suggest they are more experienced and comfortable with web-based modalities. In multivariable analysis, only younger age was associated with increased receptivity to participate in cancer risk reduction programs. This suggests that younger individuals may be more open to interventions, especially if they can anticipate benefits from the programs that decrease cancer risk.

This study found that the timing of the PC patient’s diagnosis did not affect the family member’s receptivity to participate in lifestyle interventions. However, a limitation is that family members were surveyed on average seven years after the patient was diagnosis with PC, and thus we may not have fully captured the range of possible responses based on early time since diagnosis (less than 2 years). Despite this finding, it is possible that actual participation, treatment compliance, and/or effectiveness of interventions would be different based on duration since diagnosis. Other factors such as emotional reactions, fatigue related to caregiving, or concern about their own cancer risk may also influence program participation and treatment engagement. Future studies including a shorter time since diagnosis would be necessary to accurately assess these additional factors. In the area of PC, additional work is needed to understand the impact of this cancer on family members’ perceived vulnerability and willingness to confront the potential relationships between their own behavior and their cancer risk. Similarly, it is unclear what aspects of the cancer experience should be incorporated into lifestyle programs for families affected by PC that take into account their unique needs and concerns. For instance, mental health concerns (e.g., anxiety, depression) are heightened in spouses and partners of cancer patients; the particularly poor prognosis for PC suggests that issues of mental health deserve special attention, as depression and anxiety are known to interfere with participation and success in behavior change programs [26]. In addition, the degree of connection to the family cancer experience such as emotional and cognitive involvement and perceived similarity to the affected person [27] could be assessed in subsequent work.

There is limited information about how one’s behavioral intentions may be different from actual behavior change, especially with at-risk cancer populations. There is some evidence that patient’s often feel like behavioral modification will have little impact on their prognosis, and therefore are less likely to put forth effort to make change [28]. It has been found that patient perceptions of the effectiveness of positive lifestyle changes (dietary changes, exercise, weight loss) and medical recommendations (following recommendations for screenings) are a key part in the decision-making process used to determine the extent of their medical recommendation adherence [29]. It would be valuable to explore these topics in this population to assess if intentions match actual behavioral change.

There are strengths and limitations in this study. As the purpose of this study was to explore the preferences and receptivity to lifestyle programs centered on the family cancer experience, we utilized an existing PC family registry. Our results may not replicate in families with other cancers. In addition, although we employed analytic strategies (i.e., GEE) to account for possible non-independence in the data, our results should be interpreted with caution. Finally, our sample was very homogeneous, primarily white, limiting our ability to generalize the findings to other racial or ethnic groups who are not spared the risk of PC and other cancers. Future research should be conducted with other ethnic groups and in other countries to explore how cultural differences may impact interest levels in lifestyle interventions aimed at reducing cancer risk. Strengths of this study include the use of validated measures, the large sample size, and the use of an existing family registry which made our study cost-effective and feasible.

Conclusion

In conclusion, our data suggest that family-based cancer risk reduction programs may be a promising addition to cancer prevention efforts. Utilizing newsletters or Web/Internet-based technology will expand the reach of such programs and may be more cost-effective than in-person interventions, although each of these must be carefully evaluated. Our findings provide important preliminary data that investigators can use to translate lifestyle research to the cancer survivor communities.

References

  1. Petrin K, Bowen DJ, Alfano CM, Bennett R: Adjusting to pancreatic cancer: perspectives from first-degree relatives. Palliat Support Care 2009,7(3):281–288. 10.1017/S1478951509990204

    Article  PubMed  Google Scholar 

  2. American Cancer Society (ACS): Cancer fact and figures 2010. 2010. . Accessed March 10 2011 http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf

    Google Scholar 

  3. Baum A, Andersen BL: Psychosocial interventions for cancer. Washington, DC, US: American Psychological Association; 2001.

    Book  Google Scholar 

  4. Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, Goldstein L, James J, Engstrom P: Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993,85(13):1074–1080. 10.1093/jnci/85.13.1074

    Article  CAS  PubMed  Google Scholar 

  5. Hart AR, Kennedy H, Harvey I: Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 2008,6(3):275–282. 10.1016/j.cgh.2007.12.041

    Article  PubMed  Google Scholar 

  6. Steinberg WM, Barkin JS, Bradley EL 3rd, DiMagno E, Layer P, Canto MI, Levy MJ: Should patients with a strong family history of pancreatic cancer be screened on a periodic basis for cancer of the pancreas? Pancreas 2009,38(5):e137-e150. 10.1097/MPA.0b013e3181a86b2c

    Article  PubMed  Google Scholar 

  7. Anderson LN, Cotterchio M, Gallinger S: Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario Canada. Cancer Causes Control 2009,20(6):825–834. 10.1007/s10552-009-9303-5

    Article  PubMed  PubMed Central  Google Scholar 

  8. Giovannucci E, Michaud D: The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007,132(6):2208–2225. 10.1053/j.gastro.2007.03.050

    Article  CAS  PubMed  Google Scholar 

  9. Larsson SC, Orsini N, Wolk A: Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer 2007,120(9):1993–1998. 10.1002/ijc.22535

    Article  CAS  PubMed  Google Scholar 

  10. Luo J, Iwasaki M, Inoue M, Sasazuki S, Otani T, Ye W, Tsugane S: Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan–the JPHC study. Cancer Causes Control 2007,18(6):603–612. 10.1007/s10552-007-9002-z

    Article  PubMed  Google Scholar 

  11. Kristeller JL, Hebert J, Edmiston K, Liepman M, Wertheimer M, Ward A, Luippold R: Attitudes toward risk factor behavior of relatives of cancer patients. Prev Med 1996,25(2):162–169. 10.1006/pmed.1996.0042

    Article  CAS  PubMed  Google Scholar 

  12. Lemon SC, Zapka JG, Clemow L: Health behavior change among women with recent familial diagnosis of breast cancer. Prev Med 2004,39(2):253–262. 10.1016/j.ypmed.2004.03.039

    Article  PubMed  Google Scholar 

  13. Carlos RC, Dempsey AF, Patel DA, Dalton VK: Cervical cancer prevention through human papillomavirus vaccination: using the "teachable moment" for educational interventions. Obstet Gynecol 2010,115(4):834–838. 10.1097/AOG.0b013e3181d502d7

    Article  PubMed  PubMed Central  Google Scholar 

  14. McBride CM, Ostroff JS: Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control 2003,10(4):325–333.

    PubMed  Google Scholar 

  15. Sutherland G, White V: Teachable moments in diet and nutrition for family and friends calling the Cancer Helpline. Aust N Z J Public Health 2005,29(4):388–389. 10.1111/j.1467-842X.2005.tb00213.x

    Article  PubMed  Google Scholar 

  16. Baider L, Surbone A: Cancer and the family: the silent words of truth. J Clin Oncol 2010,28(7):1269–1272. 10.1200/JCO.2009.25.1223

    Article  PubMed  Google Scholar 

  17. Garces YI, Patten CA, Sinicrope PS, Decker PA, Offord KP, Brown PD, Clark MM, Rummans TA, Foote RL, Hurt RD: Willingness of cancer patients to help family members to quit smoking. Psychooncology 2011,20(7):724–729. 10.1002/pon.1768

    Article  PubMed  Google Scholar 

  18. McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, Petersen GM: Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008,68(12):4928–4935. 10.1158/0008-5472.CAN-07-5539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Faschingbauer T, Zisook S, DeVaul R: The Texas revised inventory of grief. In Biopsychosocial Aspects of Breavement. Edited by: Zisook S. Washington, DC: American Psychiatric Press; 1987:111–124.

    Google Scholar 

  20. Jerusalem M, Schwarzer R: Self-efficacy as a resource factor in stress appraisal process. In Self-efficacy: Thought control of action. Edited by: Schwarzer R. Washington, D.C: Hemisphere; 1992:195–213.

    Google Scholar 

  21. Schwarzer R, Renner B: Health Specific Self-Efficacy Scales. Berlin: Germany; 1996.

    Google Scholar 

  22. Marcus BH, Selby VC, Niaura RS, Rossi JS: Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 1992,63(1):60–66. 10.1080/02701367.1992.10607557

    Article  CAS  PubMed  Google Scholar 

  23. Godin G, Shephard RJ: A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985,10(3):141–146.

    CAS  PubMed  Google Scholar 

  24. Cohen S: Social relationships and health. Am Psychol 2004,59(8):676–684.

    Article  PubMed  Google Scholar 

  25. Hay JL, Buckley TR, Ostroff JS: The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology 2005,14(7):517–534. 10.1002/pon.864

    Article  PubMed  Google Scholar 

  26. Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR: Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol 2007,25(11):1403–1411. 10.1200/JCO.2006.07.5705

    Article  PubMed  Google Scholar 

  27. Hawkins NA, McCarty F, Peipens LA, Rodriquez JL: Measuring the degree of closeness to the cancer experience: development and initial validation of the CONNection to the Experience of Cancer Scale (CONNECS). Patient Educ Counseling 2012,89(2):292–299. 10.1016/j.pec.2012.08.009

    Article  Google Scholar 

  28. Gulanick M, Bliley A, Perino B, Keough V: Recovery patterns and lifestyle changes after coronary angioplasty: the patient's perspective. Heart Lung 1998,27(4):253–262. 10.1016/S0147-9563(98)90037-1

    Article  CAS  PubMed  Google Scholar 

  29. Speechly C, Bridges-Webb C, McKenzie S, Zurynski Y, Lucas A: Patient and general practitioner attitudes to healthy lifestyle behaviours and medication following coronary heart disease: an exploratory study. Aus J Primary Health 2010,16(2):154–158. 10.1071/PY09011

    Article  Google Scholar 

Download references

Acknowledgments

We thank the study participants, and Jodie Cogswell, Maureen Griffin, Traci Hammer, Que Luu, Dennis Robinson, and Cindy Wong for their contributions to the study. We especially thank Gail Bierbaum for assistance in preparing this manuscript. This work was supported by the Mayo Foundation and National Cancer Institute grants R01 CA97075 (G. Petersen, PI) and P50 CA102701 (G. Petersen, PI). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute nor does mention of trade names, commercial products or organization imply endorsement by the US Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christi A Patten.

Additional information

Competing interests

The author(s) declare that they have no competing interests.

Authors’ contributions

LAH, PSS, CAP, and GMP conceived of the study, participated in the study design, and constructed the survey. PSS and TAB coordinated the research efforts and data collection. PAD, AN, and KGR performed the statistical analysis. LAH, PSS, TAB, CAP, SLE, CRB and GMP made contributions to interpretation of the data and drafted of the manuscript. All authors read and approved the final manuscript.

Lisa A Howell, Pamela S Sinicrope, Tabetha A Brockman, Christi A Patten, Paul A Decker, Shawna L Ehlers, Ashley Nadeau, Kari G Rabe, Carmen Radecki Breitkopf and Gloria M Petersen contributed equally to this work.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Howell, L.A., Sinicrope, P.S., Brockman, T.A. et al. Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk. Hered Cancer Clin Pract 11, 3 (2013). https://doi.org/10.1186/1897-4287-11-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1897-4287-11-3

Keywords